SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Omkar Speciality files patent for preparation of Cardiovascular drug

09 Mar 2018 Evaluate

Omkar Speciality Chemicals has applied for grant of patent for ‘Process for preparation of Cardiovascular drug key intermediate 2-butyl-3-(3,5-diiodo-4-hydroxybenzoyl) benzofuran’. This intermediate has been developed for first time in India. Till date, all supplies were from foreign markets. The company is pioneer in developing and supplying this intermediate with finest quality.

Omkar Speciality Chemicals is one of the leading players in the manufacturing of Speciality Chemicals and Veterinary APIs. The company manufactures a range of Organic, Inorganic and Organo Inorganic Intermediates.


Omkar SpecialityChem Share Price

4.09 -0.21 (-4.88%)
20-Apr-2026 14:24 View Price Chart
Peers
Company Name CMP
BASF India 3663.50
Tata Chemicals 703.75
SRF 2465.25
Pidilite Inds. 1391.05
Deepak Nitrite 1536.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×